Figure 2From: Cancer/Testis antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomyCancer/Testis Antigen (CTA) expression in recurrent and non-recurrent prostate cancer. CTA expression in clinically localized prostate cancer with recurrence (Rec (+)) (n = 43) and without recurrence (Rec (-)) (n = 29). (A) CEP55, (B) NUF2, (C) PAGE4, (D) PBK, (E) TTK.Back to article page